BioStem Technologies, Inc.
BSEM
$4.38
-$0.46-9.60%
OTC PK
| 06/30/2025 | 03/31/2025 | 09/30/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 49.30M | 72.53M | 82.56M | 82.56M | 74.49M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 49.30M | 72.53M | 82.56M | 82.56M | 74.49M |
| Cost of Revenue | 685.20K | 853.40K | 4.24M | 4.24M | 3.75M |
| Gross Profit | 48.61M | 71.67M | 78.32M | 78.32M | 70.74M |
| SG&A Expenses | 46.48M | 64.68M | 68.49M | 68.49M | 61.79M |
| Depreciation & Amortization | 60.70K | 54.00K | 56.80K | 56.80K | 54.10K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 49.18M | 67.28M | 73.26M | 73.26M | 65.67M |
| Operating Income | 112.80K | 5.25M | 9.29M | 9.29M | 8.82M |
| Income Before Tax | 178.00K | 5.28M | 9.15M | 9.15M | 8.60M |
| Income Tax Expenses | 742.30K | 797.40K | 2.33M | 2.33M | 2.31M |
| Earnings from Continuing Operations | -564.40K | 4.48M | 6.82M | 6.82M | 6.29M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -564.40K | 4.48M | 6.82M | 6.82M | 6.29M |
| EBIT | 112.80K | 5.25M | 9.29M | 9.29M | 8.82M |
| EBITDA | 173.50K | 5.30M | 9.35M | 9.35M | 8.88M |
| EPS Basic | -0.03 | 0.27 | 0.42 | 0.42 | 0.39 |
| Normalized Basic EPS | 0.01 | 0.20 | 0.35 | 0.35 | 0.33 |
| EPS Diluted | -0.03 | 0.17 | 0.32 | 0.32 | 0.30 |
| Normalized Diluted EPS | 0.01 | 0.13 | 0.27 | 0.27 | 0.26 |
| Average Basic Shares Outstanding | 16.71M | 16.67M | 16.32M | 16.32M | 16.30M |
| Average Diluted Shares Outstanding | 16.71M | 26.26M | 21.13M | 21.13M | 20.92M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |